List of biOasis Technologies patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9364567 Fragments of p97 and uses thereof	Patent 9364567 was granted and assigned to biOasis Technologies on June, 2016 by the United States Patent and Trademark Office.	‌ biOasis Technologies	‌ biOasis Technologies	United States Patent and Trademark Office	9364567	June 14, 2016
‌ US Patent 11643454 P97 fusion proteins	Patent 11643454 was granted and assigned to biOasis Technologies on May, 2023 by the United States Patent and Trademark Office.	‌ biOasis Technologies	‌ biOasis Technologies	United States Patent and Trademark Office	11643454	May 9, 2023
‌ US Patent 8722019 P97 fragments with transfer activity	Patent 8722019 was granted and assigned to biOasis Technologies on May, 2014 by the United States Patent and Trademark Office.		‌ biOasis Technologies	United States Patent and Trademark Office	8722019	May 13, 2014
‌ US Patent 9850472 P97-antibody conjugates and methods of use	Patent 9850472 was granted and assigned to biOasis Technologies on December, 2017 by the United States Patent and Trademark Office.	‌ biOasis Technologies	‌ biOasis Technologies	United States Patent and Trademark Office	9850472	December 26, 2017
‌ US Patent 9150846 P97-antibody conjugates and methods of use	Patent 9150846 was granted and assigned to biOasis Technologies on October, 2015 by the United States Patent and Trademark Office.		‌ biOasis Technologies	United States Patent and Trademark Office	9150846	October 6, 2015
‌ US Patent 11124781 P97-IDS fusion proteins	Patent 11124781 was granted and assigned to biOasis Technologies on September, 2021 by the United States Patent and Trademark Office.		‌ biOasis Technologies	United States Patent and Trademark Office	11124781	September 21, 2021